CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-11 | Sabag Mark See "Remarks" below | Option exercise | +37,884 | 58,482 | ||
| 2021-05-11 | Sabag Mark See "Remarks" below | Option exercise · Restricted Share Units | −37,884 | 0 | ||
| 2021-05-11 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +37,884 | 111,337.51 | ||
| 2021-05-11 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −19,066 | $10.22 | $195K | 92,271.51 |
| 2021-05-11 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −37,884 | 0 | ||
| 2021-05-11 | Drape Eric Executive VP Global Operations | Option exercise | +37,884 | 92,932 | ||
| 2021-05-11 | Drape Eric Executive VP Global Operations | Sale | −19,804 | $10.22 | $202K | 73,128 |
| 2021-05-11 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units | −37,884 | 0 | ||
| 2021-03-16 | Sabag Mark See "Remarks" below | Sale | −127,244 | $11.22 | $1.4M | 20,598 |
| 2021-03-05 | Stark David Matthew Exec. VP Chief Legal Officer | Grant or award · Restricted Share Units | +80,798 | 80,798 | ||
| 2021-03-05 | Schultz Kare President and CEO | Grant or award · Restricted Share Units | +285,171 | 285,171 | ||
| 2021-03-05 | Sabag Mark See "Remarks" below | Grant or award · Restricted Share Units | +95,057 | 95,057 | ||
| 2021-03-05 | O'Grady Brendan P. EVP, North America Commercial | Sale | −11,436 | $10.54 | $121K | 14,868.49 |
| 2021-03-05 | O'Grady Brendan P. EVP, North America Commercial | Grant or award · Restricted Share Units | +109,315 | 109,315 | ||
| 2021-03-05 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Grant or award · Restricted Share Units | +85,551 | 85,551 | ||
| 2021-03-05 | Fridriksdottir Hafrun Executive VP, Global R&D | Grant or award · Restricted Share Units | +95,057 | 95,057 | ||
| 2021-03-05 | Drape Eric Executive VP Global Operations | Grant or award · Restricted Share Units | +90,304 | 90,304 | ||
| 2021-03-05 | Dethlefs Sven EVP Global Marketing&Portfolio | Grant or award · Restricted Share Units | +99,809 | 99,809 | ||
| 2021-03-05 | Daniell Richard Exec. VP, European Commercial | Grant or award · Restricted Share Units | +90,304 | 90,304 | ||
| 2021-03-04 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +13,930 | 16,904.39 |
Page 46 of 76 · 1,517 trades